Introduced
by
To establish that a rebate or discount from a drug manufacturer that benefits a consumer does not violate a “false claims” law that bans kickbacks and bribes health care insurance.
Referred to the Committee on Health Policy and Human Services
Reported without amendment
With the recommendation that the bill pass.
Passed in the Senate 37 to 0 (details)
Referred to the Committee on Health Policy
Reported without amendment
Refer to the Committee on Ways and Means.
Referred to the Committee on Ways and Means
Reported without amendment
Without amendment and with the recommendation that the bill pass.
Passed in the House 100 to 0 (details)
To establish that a rebate or discount from a drug manufacturer that benefits a consumer does not violate a “false claims” law that bans kickbacks and bribes health care insurance.
